Masonic Cancer Center, University Of Minnesota
Clinical trials sponsored by Masonic Cancer Center, University Of Minnesota, explained in plain language.
-
New drug cocktail shows promise for tough prostate cancer
Disease control CompletedThis phase II trial tested a combination of three drugs—carboplatin, cabazitaxel, and abiraterone—in 61 men with high-volume metastatic prostate cancer that still responds to hormone therapy. The goal was to see how many men had no cancer growth after one year. The study also tra…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New combo therapy aims to tame stem cell transplant complications
Disease control CompletedThis study tested a new drug called VIC-1911 added to standard medications to prevent graft-versus-host disease (GVHD) in 16 adults with blood cancers receiving a stem cell transplant. The goal was to find a safe and effective dose that reduces GVHD and relapse. Results are still…
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a watercress drink help flush out Cancer-Causing chemicals?
Disease control CompletedThis study tested whether two specially prepared drinks, one made from freeze-dried watercress, can help the body get rid of harmful environmental chemicals that may cause cancer. Three hundred healthy adults, including smokers and non-smokers, drank the preparations three times …
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug aims to boost immune system against tough cancers
Disease control CompletedThis early-phase trial tested a new drug called HCW9218 in 18 people with advanced solid tumors that had not responded to at least two prior treatments. The drug is designed to both activate immune cells and block signals that help tumors grow. The main goal was to find a safe do…
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can physical therapy ease arm pain after breast cancer surgery?
Symptom relief CompletedThis study looks at whether physical therapy can help breast cancer patients who develop axillary web syndrome (a condition causing tight, painful cords under the arm) after surgery. Researchers will compare patients who receive physical therapy to those who don't, measuring impr…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Last-resort radiation treatment offers hope for rare childhood and adult cancers
Symptom relief CompletedThis study gave a radioactive drug called 131I-MIBG to 15 people with advanced nerve tumors (neuroblastoma or pheochromocytoma) that had stopped responding to standard treatments. The goal was to see if it could ease symptoms and shrink tumors, while tracking side effects. Partic…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Sweet smokes? study tests if sugar boosts cigarette appeal
Knowledge-focused CompletedThis study looked at how the amount of sugar in cigarette tobacco affects how much people enjoy smoking and how addictive the cigarettes seem. Thirty adult smokers tested cigarettes with different sugar levels and answered questionnaires about their experience. The goal was to se…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Can a phone study track how cigarette design changes smoking habits?
Knowledge-focused CompletedThis study tested whether a remote, telehealth approach can work to study how cigarette filter ventilation (the tiny holes in the filter) affects smoking behavior and exposure to harmful chemicals. 64 adult smokers participated from home, using their own devices for video visits …
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC